Trials / Sponsors / Ray Therapeutics, Inc.
Ray Therapeutics, Inc.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherit Retinitis Pigmentosa, Stargardt Macular Dystrophy, Stargardt Disease | — | 2026-02-19 |
| Recruiting | Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Stargardt Disease | Phase 1 / Phase 2 | 2026-01-28 |
| Active Not Recruiting | Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) Retinitis Pigmentosa, Choroideremia | Phase 1 | 2024-08-27 |
| Recruiting | Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retin Retinitis Pigmentosa, Choroideremia, Stargardt Macular Dystrophy | — | 2024-04-05 |